GOP-led Congress rejects Trump’s plans to gut medical research
Senate bill gives NIH a $400 million raise

Vinay Prasad falls from grace at FDA upon flunking Trump political purity test
MAHA leaders agree on one point: COVID was mishandled. Is that enough to run science-based agencies?

U.S. News & World Report expands evaluation of outcomes in cancer subspecialties

USPSTF doesn’t lean right or left—it’s about data, not politics

Will MCD tests revolutionize cancer screening? NCI begins enrollment in Vanguard “feasibility” trial to start finding out

Cancer Policy

UPenn study supports continued use of ODAC voting

FY25 paylines drop to 4th percentile—a historic low—as NCI braces for Trump’s FY26 budget cuts

Right-wing provocateur Laura Loomer comes for FDA’s Vinay Prasad

The effects of NIH, FDA cuts will be felt for decades, CBO report estimates

COI statement prohibits “unseemly advocacy,” “undue influence” by industry rep on ODAC

Columbia settles with Trump, agreeing to a $200M fine, as Harvard fights on

Clinical Roundup

Cannabis use disorder triples risk of oral cancer, UCSD study finds

Blood tests show potential for CRC detection, but follow-up falls short

IGRT shows no reduction in serious infections for patients with CLL

Respiratory viruses can wake up breast cancer cells in lungs, preclinical study shows

Blocking macropinocytosis changes TME, allows for more effective treatment, preclinical study shows

T cells and B cells join to fight solid tumors, Winship study finds

In The Clinic

First-ever financial toxicity tumor board aims to change the standard of care
Researchers focus on debt as a side effect of cancer, treatment amid cuts to Medicaid, NCI

An overlooked immune cell population may offer new direction for cell and gene therapy

She flew Black Hawks and battled cancer—now Col. Susan Fondy grapples with cuts to lymphedema research

How MD Anderson and Texas Children’s made plans to build a $1 billion pediatric cancer hospital—one of the world’s largest

As cancer patients use AI chatbots, dangers lurk—but new safeguards can help

Latest Issue

NEWS ALERTS

Stay up to date on the latest news in oncology by joining our mailing list.

UPCOMING EVENTS

Sep 2025

Oct 2025

Conversations with The Cancer Letter

Robert Winn: If Medicaid gets massive cuts or goes away, where will these patients get care?

HHS seems poised to exert control over USPSTF
Ransohoff: The task force is the pinnacle of evidence-based medicine

Lou Weisbach tells us about his plan to raise $750 billion for the American Center for Cures

We catch up with Kimryn Rathmell on her first day as CEO at OSUCCC – James

Contributors

Richard T. Lee, MD

Jeff Sorenson

Robert Peter Gale, MD, PhD, DSc (hon), FACP, FRCP, FRCPI(hon), FRSM

Charles Brenner, PhD

GOP-led Congress rejects Trump’s plans to gut medical research
Senate bill gives NIH a $400 million raise

Vinay Prasad falls from grace at FDA upon flunking Trump political purity test
MAHA leaders agree on one point: COVID was mishandled. Is that enough to run science-based agencies?

U.S. News & World Report expands evaluation of outcomes in cancer subspecialties

USPSTF doesn’t lean right or left—it’s about data, not politics

Will MCD tests revolutionize cancer screening? NCI begins enrollment in Vanguard “feasibility” trial to start finding out

UPenn study supports continued use of ODAC voting

FY25 paylines drop to 4th percentile—a historic low—as NCI braces for Trump’s FY26 budget cuts

Right-wing provocateur Laura Loomer comes for FDA’s Vinay Prasad

The effects of NIH, FDA cuts will be felt for decades, CBO report estimates

COI statement prohibits “unseemly advocacy,” “undue influence” by industry rep on ODAC

Columbia settles with Trump, agreeing to a $200M fine, as Harvard fights on

Cannabis use disorder triples risk of oral cancer, UCSD study finds

Blood tests show potential for CRC detection, but follow-up falls short

IGRT shows no reduction in serious infections for patients with CLL

Respiratory viruses can wake up breast cancer cells in lungs, preclinical study shows

Blocking macropinocytosis changes TME, allows for more effective treatment, preclinical study shows

T cells and B cells join to fight solid tumors, Winship study finds

First-ever financial toxicity tumor board aims to change the standard of care
Researchers focus on debt as a side effect of cancer, treatment amid cuts to Medicaid, NCI

An overlooked immune cell population may offer new direction for cell and gene therapy

She flew Black Hawks and battled cancer—now Col. Susan Fondy grapples with cuts to lymphedema research

How MD Anderson and Texas Children’s made plans to build a $1 billion pediatric cancer hospital—one of the world’s largest

As cancer patients use AI chatbots, dangers lurk—but new safeguards can help

Robert Winn: If Medicaid gets massive cuts or goes away, where will these patients get care?

HHS seems poised to exert control over USPSTF
Ransohoff: The task force is the pinnacle of evidence-based medicine

Lou Weisbach tells us about his plan to raise $750 billion for the American Center for Cures

We catch up with Kimryn Rathmell on her first day as CEO at OSUCCC – James

Richard T. Lee, MD

Jeff Sorenson

Robert Peter Gale, MD, PhD, DSc (hon), FACP, FRCP, FRCPI(hon), FRSM

Charles Brenner, PhD

Never miss an issue!

Login

GOP-led Congress rejects Trump’s plans to gut medical researchSenate bill gives NIH a $400 million raise

Robert Winn: If Medicaid gets massive cuts or goes away, where will these patients get care?

HHS seems poised to exert control over USPSTFRansohoff: The task force is the pinnacle of evidence-based medicine

Lou Weisbach tells us about his plan to raise $750 billion for the American Center for Cures

We catch up with Kimryn Rathmell on her first day as CEO at OSUCCC – James

Never miss an issue!

Login

GOP-led Congress rejects Trump’s plans to gut medical research
Senate bill gives NIH a $400 million raise

HHS seems poised to exert control over USPSTF
Ransohoff: The task force is the pinnacle of evidence-based medicine